drugset / Trial / NCT01296464

Comparing Different Levodopa/Carbidopa/Entacapone Treatment Regimens

NCT01296464

Phase 2 Completed 27 enrolled Orion Corporation, Orion Pharma
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The primary objective is to assess the effect of a single dose of two experimental levodopa/carbidopa/entacapone (L/C/E) treatment regimens versus standard L/C/E treatment regimen in Parkinson's disease (PD) patients with end-of-dose motor fluctuations in terms of duration of motor response after the first morning dose of levodopa. The secondary objective is to evaluate the safety of the L/C/E treatment regimens in patients with PD.

Timeline

Start
2011-02
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbidopa Unknown

Indications